Tumors of female reproductive systemTumors of female reproductive systemОпухоли женской репродуктивной системы1994-40981999-8627Publishing House ABV Press48410.17650/1994-4098-2016-12-1-98-104GYNECOLOGY. CLINICAL OBSERVATIONSГИНЕКОЛОГИЯ. КЛИНИЧЕСКИЕ НАБЛЮДЕНИЯMagnetic resonance imaging in the differential diagnosis of true placenta accreta: a clinical caseМагнитно-резонансная томография в дифференциальной диагностике истинного приращения плаценты: клинический случайTarachkovaE. V.ТарачковаЕ. В.
Russian Federation
doctorkid@yandex.ruMeshcheryakovaL. A.МещеряковаЛ. А.
Russian Federation
ShorikovM. A.ШориковМ. А.
Russian Federation
MaslennikovA. F.МасленниковА. Ф.
Russian Federation
PanovV. O.ПановВ. О.
Russian Federation
KuznetsovV. V.КузнецовВ. В.
Russian Federation
Russian Medical Academy of Postgraduate Education, Ministry of Health of RussiaГБОУ ДПО «Российская медицинская академия последипломного образования» Минздрава России2/1 Barrikadnaya St., Moscow, 125993, RussiaРоссия, 123995, Москва, ул. Баррикадная, 2/1, стр. 1Research Institute of Clinical and Experimental Radiology, N.N. Blokhin Russian Cancer Research Center, Ministry of Health of RussiaНаучно-исследовательский институт клинической и экспериментальной радиологии ФГБУ «РОНЦ им. Н.Н. Блохина» Минздрава России23 Kashirskoe Shosse, Moscow, 115478, RussiaРоссия, 115478, Москва, Каширское шоссе, 2306062016121981040606201606062016https://ojrs.abvpress.ru/ojrs/article/view/484

True placenta accreta is the attachment of chorionic villi to the myometrium, possibly penetrating into the thickness of the myometrium and its outside, including through the serous tunic. The main current diagnostic techniques are considered to be ultrasonography, laboratory diagnosis (elevated human chorionic gonadotropin and placental lactogen levels), and clinical data (pain and vaginal discharge). Magnetic resonance imaging is deemed to be an adjuvant technique. By using a clinical example, this paper considers the capabilities of magnetic resonance imaging to diagnose this abnormality and to choose a right treatment policy. The abnormality is compared with the conditions (trophoblastic tumor and myoma with lysis) that are similar in their diagnosis and magnetic resonance pattern). The disorder in question is rather rare and its detailed consideration, determination of the capabilities of various techniques, and comparison with externally similar cases areimportant for the development of diagnostic opportunities.

Истинное приращение плаценты – это прорастание ворсинок хориона до миометрия с возможным проникновением в толщу миометрия и за его пределы, в том числе и сквозь серозную оболочку. Основными методами диагностики в настоящее время считаются ультрасонографический метод, лабораторная диагностика (повышение хориогонадотропина человека и плацентарного лактогена), клинические данные (боли и наличие выделений из половых путей). Магнитно-резонансная диагностика считается вспомогательным методом. В настоящей статье рассмотрены на клиническом примере возможности магнитно-резонансной томографии для диагностики этой патологии и для выбора правильной тактики лечения. Проведено сравнение со сходными на диагностическом этапе (в том числе и по магнитно-резонансной картине) патологиями – трофобластической опухолью и миомой с распадом. Изучаемая патология является достаточно редкой, и ее подробное рассмотрение, выявление возможностей различных методов и сравнение с внешне сходными случаями важны для развития возможностей диагностики.

magnetic resonance imagingtrue placenta accretetrophoblastic tumorsdifferential diagnosismyoma with lysisuterine extirpationclinical laboratory diagnosishuman chorionic gonadotropinplacental lactogenмагнитно-резонансная томографияистинное приращение плацентыplacenta accretaтрофобластические опухолидифференциальный диагнозмиома с распадомэкстирпация маткиклиническая лабораторная диагностикахориогонадотропин человекаплацентарный лактоген1. Avva R., Shah H.R., Angtuaco T.L. US case of the day. Placenta increta. Radiographics 1999;19(4): 1089–92.Avva R., Shah H.R., Angtuaco T.L. US case of the day. Placenta increta. Radiographics 1999;19(4): 1089–92.2. Krapp M., Baschat A.A., Hankeln M., Gembruch U. Gray scale and color Doppler sonography in the third stage of labor for early detection of failed placental separation. Ultrasound Obstet Gynecol 2000;15(2): 138–42.Krapp M., Baschat A.A., Hankeln M., Gembruch U. Gray scale and color Doppler sonography in the third stage of labor for early detection of failed placental separation. Ultrasound Obstet Gynecol 2000;15(2): 138–42.3. Garmi G., Salim R. Epidemiology, etiology, diagnosis, and management of placenta accreta. Obstet Gynecol Int 2012;2012:873929.Garmi G., Salim R. Epidemiology, etiology, diagnosis, and management of placenta accreta. Obstet Gynecol Int 2012;2012:873929.4. Cramer S.F., Heller D. Placenta accreta and placenta increta – an approach to pathogenesis based on the trophoblastic differentiation pathway. Pediatr Dev Pathol 2015. [Epub ahead of print].Cramer S.F., Heller D. Placenta accreta and placenta increta – an approach to pathogenesis based on the trophoblastic differentiation pathway. Pediatr Dev Pathol 2015. [Epub ahead of print].5. Beuker J.M., Erwich J.J., Khong T.Y. Is endomyometrial injury during termination of pregnancy or curettage following miscarriage the precursor to placenta accreta? J Clin Pathol 2005;58(3):273–5.Beuker J.M., Erwich J.J., Khong T.Y. Is endomyometrial injury during termination of pregnancy or curettage following miscarriage the precursor to placenta accreta? J Clin Pathol 2005;58(3):273–5.6. Sakinci M., Kuru O., Tosun M. et al. Clinical analysis of emergency peripartum hysterectomies in a tertiary center. Clin Exp Obstet Gynecol 2014;41(6): 654–8.Sakinci M., Kuru O., Tosun M. et al. Clinical analysis of emergency peripartum hysterectomies in a tertiary center. Clin Exp Obstet Gynecol 2014;41(6): 654–8.7. Clausen C., Lonn L., Langhoff-Roos J. Management of placenta percreta: a review of published cases. Acta Obstet Gynecol Scand 2014;93(2):138–43.Clausen C., Lonn L., Langhoff-Roos J. Management of placenta percreta: a review of published cases. Acta Obstet Gynecol Scand 2014;93(2):138–43.8. Androutsopoulos G., Gkogkos P., Decavalas G. Mid-trimester maternal serum HCG and alpha fetal protein levels: clinical significance and prediction of adverse pregnancy outcome. Int J Endocrinol Metab 2013;11(2):102–6.Androutsopoulos G., Gkogkos P., Decavalas G. Mid-trimester maternal serum HCG and alpha fetal protein levels: clinical significance and prediction of adverse pregnancy outcome. Int J Endocrinol Metab 2013;11(2):102–6.9. Baughman W.C., Corteville J.E., Shah R.R. Placenta accreta: spectrum of US and MR imaging findings. Radiographics 2008;28(7):1905–16.Baughman W.C., Corteville J.E., Shah R.R. Placenta accreta: spectrum of US and MR imaging findings. Radiographics 2008;28(7):1905–16.10. Dwyer B.K., Belogolovkin V., Tran L. et al. Prenatal diagnosis of placenta accreta: sonography or magnetic resonance imaging? J Ultrasound Med 2008;27(9):1275–81.Dwyer B.K., Belogolovkin V., Tran L. et al. Prenatal diagnosis of placenta accreta: sonography or magnetic resonance imaging? J Ultrasound Med 2008;27(9):1275–81.11. Hoffman J.S., Silverman A.D., Gelber J., Cartun R. Placental site trophoblastic tumor: a report of radiologic, surgical, and pathologic methods of evaluating the extent of disease. Gynecol Oncol 1993;50(1): 110–4.Hoffman J.S., Silverman A.D., Gelber J., Cartun R. Placental site trophoblastic tumor: a report of radiologic, surgical, and pathologic methods of evaluating the extent of disease. Gynecol Oncol 1993;50(1): 110–4.12. Abulafia O., Sherer D.M., Fultz P.J. et al. Unusual endovaginal ultrasonography and magnetic resonance imaging of placental site trophoblastic tumor. Am J Obstet Gynecol 1994;170(3):750–2.Abulafia O., Sherer D.M., Fultz P.J. et al. Unusual endovaginal ultrasonography and magnetic resonance imaging of placental site trophoblastic tumor. Am J Obstet Gynecol 1994;170(3):750–2.13. Brandt K.R., Coakley K.J. MR appearance of placental site trophoblastic tumor: a report of three cases. Am J Roentgenol 1998;170(2): 485–7.Brandt K.R., Coakley K.J. MR appearance of placental site trophoblastic tumor: a report of three cases. Am J Roentgenol 1998;170(2): 485–7.14. Стрельцова О.Н., Мещерякова Л.А., Тарачкова Е.В. и др. Магнитно-резонансная томография в диагностике трофобластической опухоли плацентарного ложа. Вестник РОНЦ им. Н.Н. Блохина 2014;25(3–4):107–10. [Strel’tsovа О.N., Меshcheryakovа L.А., Таrachkovа Е.V. et al. Маgnetic and resonance tomography in the diagnostics of the placental site trophoblastic tumor. Vesnik RONC im. N.N. Blokhina = Herald of N.N. Blokhin RCRC 2014;25 (3–4):107–10. (In Russ.)].Стрельцова О.Н., Мещерякова Л.А., Тарачкова Е.В. и др. Магнитно-резонансная томография в диагностике трофобластической опухоли плацентарного ложа. Вестник РОНЦ им. Н.Н. Блохина 2014;25(3–4):107–10. [Strel’tsovа О.N., Меshcheryakovа L.А., Таrachkovа Е.V. et al. Маgnetic and resonance tomography in the diagnostics of the placental site trophoblastic tumor. Vesnik RONC im. N.N. Blokhina = Herald of N.N. Blokhin RCRC 2014;25 (3–4):107–10. (In Russ.)].15. Dhanda S., Ramani S., Thakur M. Gestational trophoblastic disease: a multimodality imaging approach with impact on diagnosis and management. Radiol Res Pract 2014;2014:842751.Dhanda S., Ramani S., Thakur M. Gestational trophoblastic disease: a multimodality imaging approach with impact on diagnosis and management. Radiol Res Pract 2014;2014:842751.16. Hassadia A., Gillespie A., Tidy J. et al. Placental site trophoblastic tumour: clinical features and management. Gynecol Oncol 2005;99(3):603–7.Hassadia A., Gillespie A., Tidy J. et al. Placental site trophoblastic tumour: clinical features and management. Gynecol Oncol 2005;99(3):603–7.17. Vardar M.A., Altintas A. Placental-site trophoblastic tumor. Principles of diagnosis, clinical behaviour and treatment. Eur J Gynaecol Oncol 1995;16(4): 290–5.Vardar M.A., Altintas A. Placental-site trophoblastic tumor. Principles of diagnosis, clinical behaviour and treatment. Eur J Gynaecol Oncol 1995;16(4): 290–5.18. Bower M., Paradinas F.J., Fisher R.A. et al. Placental site trophoblastic tumor: molecular analysis and clinical experience. Clin Cancer Res 1996;2(5):897–902.Bower M., Paradinas F.J., Fisher R.A. et al. Placental site trophoblastic tumor: molecular analysis and clinical experience. Clin Cancer Res 1996;2(5):897–902.19. Murase E., Siegelman E.S., Outwater E.K. et al. Uterine leiomyomas: histopathologic features, MR imaging findings, differential diagnosis, and treatment. Radiographics 1999;19(5):1179–97.Murase E., Siegelman E.S., Outwater E.K. et al. Uterine leiomyomas: histopathologic features, MR imaging findings, differential diagnosis, and treatment. Radiographics 1999;19(5):1179–97.20. Weinreb J.C., Barkoff N.D., Megibow A., Demopoulos R. The value of MR imaging in distinguishing leiomyomas from other solid pelvic masses when sonography is indeterminate. Am J Roentgenol 1990;154(2):295–9.Weinreb J.C., Barkoff N.D., Megibow A., Demopoulos R. The value of MR imaging in distinguishing leiomyomas from other solid pelvic masses when sonography is indeterminate. Am J Roentgenol 1990;154(2):295–9.21. Ueda H., Togashi K., Konishi I. et al. Unusual appearances of uterine leiomyomas: MR imaging findings and their histopathologic backgrounds. Radiographics 1999;19 Spec No:S131–45.Ueda H., Togashi K., Konishi I. et al. Unusual appearances of uterine leiomyomas: MR imaging findings and their histopathologic backgrounds. Radiographics 1999;19 Spec No:S131–45.